港股上半年IPO募资同比激增7倍，预计全年突破2000亿港元

Group 1 - The core focus of the market will be on sectors related to information technology and telecommunications, healthcare and pharmaceuticals, as well as retail, consumer goods, and services [1][3] Group 2 - The Hong Kong IPO market has significantly rebounded in the first half of the year, raising HKD 107.1 billion, a sevenfold increase compared to the same period last year, surpassing the total fundraising amount for the entire year of 2024 [2] - In the first half of the year, 44 new stocks were listed in Hong Kong, with 42 on the main board, primarily in retail, consumer goods, and services, which accounted for 34% of the listings [2] - PwC anticipates that the positive market sentiment will continue into the second half of the year, with over 200 companies having submitted applications to list in Hong Kong, covering traditional industries as well as new economy sectors like biotechnology, healthcare, and artificial intelligence [2][3] Group 3 - By the end of December 2024, there are 3 specialized technology companies under Chapter 18C and 67 biotechnology companies under Chapter 18A on the Hong Kong Stock Exchange [3] - Following the launch of the "Special Line for Science and Technology Enterprises" in May 2025, the number of biotechnology companies listed is expected to increase to 73 by June 2025 [3] - PwC predicts that 90 to 100 companies will be listed in Hong Kong in 2025, with fundraising expected to exceed HKD 200 billion, focusing on information technology and telecommunications, healthcare and pharmaceuticals, and retail, consumer goods, and services sectors [3]